Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
Other name: Chinese-American Biopharmaceutical
EIN 20-2246060 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professional in the biopharmaceutical industry. CABS is highly influential association with more than 3,000 members and subscribers in the life science industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life science corporations. We organize many activities to promote international collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in the Pacific Rim with an excellent platform to promote business and to recruit talent. CABS is helping members seeking collaboration opportunities in the Pacific Rim. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in the Pacific Rim:To CO-sponsor scientific conference in biopharmaceutical fieldTo organize C
Principal Officer
Jessica Sun
Total Revenue
$230K
FY2023
Total Expenses
$245K
FY2023
Net Assets
$288K
Program Ratio
89.5%
expenses on programs
Employees
0
Volunteers
13
Board Members
13
Voting
13
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.